Goserelin
review
OA: closed
CC0
⤵ 9 in-corpus citations
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher's page (linked below)
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
My notes (saved in your browser only)
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (92)
- 9 Endometriosis: Medical therapy via openalex
- A comparison of goserelin and danazol as endometrial thinning agents prior to endometrial laser ablation via openalex
- A Comparison of the Skeletal Effects of Goserelin and Danazol in Premenopausal Women with Endometriosis via openalex
- A gonadotropin-releasing hormone agonist versus a low-dose oral contraceptive for pelvic pain associated with endometriosis via openalex
- An alternative to hysterectomy? GnRH analogue combined with hormone replacement therapy via openalex
- ANALYSIS OF 1071 GIFT PROCEDURES—THE CASE FOR A FLEXIBLE APPROACH TO TREATMENT via openalex
- Bone mass in endometriosis patients treated with GnRH agonist implant or danazol. via openalex
- Can hormone replacement therapy be used during medical therapy of endometriosis? via openalex
- Cholesterol fractions and apolipoproteins during endometriosis treatment by a gonadotrophin releasing hormone (GnRH) agonist implant or by danazol via openalex
- Considerations in selecting appropriate medical therapy for endometriosis. via openalex
- Estrogenic suppression by different administration schedules of goserelin depot for treatment of endometriosis via openalex
- Experience with a depot GnRH-agonist (Zoladex) in the treatment of genital endometriosiss via openalex
- Goserelin via openalex
- Goserelin (Zoladex) and the skeleton via openalex
- Goserelin (Zoladex ) depot in the treatment of endometriosis via openalex
- Hormonal therapies for endometriosis: implications for bone metabolism. via openalex
- Impact of different GnRH analogs in benign gynecological disorders related to their chemical structure, delivery systems and dose via openalex
- Influence of danazol and goserelin on insulin and glucagon in non-obese women with endometriosis via openalex
- Leuprorelin via openalex
- Multiple gestation following gonadotrophin releasing hormone therapy for the treatment of minimal endometriosis via openalex
- Ovarian endometrial cysts: the role of gonadotropin-releasing hormone agonist and/or drainage via openalex
- PATHOGENESIS, DIAGNOSIS AND TREATMENT OF GENITAL ENDOMETRIOSIS via openalex
- Severe endometriosis treated with gonadotrophin releasing hormone agonist and continuous combined hormone replacement therapy via openalex
- THE EFFECT OF DANAZOL AND THE LHRH AGONIST ANALOGUE GOSERELIN (ZOLADEX) ON THE BIOLOGICAL ACTIVITY OF LUTEINIZING HORMONE IN WOMEN WITH ENDOMETRIOSIS via openalex
- Thinning the endometrium prior to ablation: is it worthwhile? via openalex
- Uses of GnRH Agonists via openalex
- Veralipride for Hot Flushes during Gonadotropin-Releasing Hormone Agonist Treatment via openalex
- Zoladex (goserelin acetate implant) in the treatment of endometriosis: a randomized comparison with danazol. The Zoladex Endometriosis Study Group. via openalex
- Zoladex® (goserelin) in the treatment of benign gynaecological disorders: an overview of safety and efficacy via openalex
- Zoladex versus Danazol in the Treatment of Pelvic Endometriosis: Effects on Plasma Lipid Risk Factors via openalex
- W2024931543 via openalex
- W2040523806 via openalex
- W2044134855 via openalex
- W2052668236 via openalex
- W2054192093 via openalex
- W2059516397 via openalex
- W2067313257 via openalex
- W2069233942 via openalex
- W2071289624 via openalex
- W2073569039 via openalex
- W2075125209 via openalex
- W2083496720 via openalex
- W2108040669 via openalex
- W2117705773 via openalex
- W2138785331 via openalex
- W2154153850 via openalex
- W2157530749 via openalex
- W2164330533 via openalex
- W2206436569 via openalex
- W2332434795 via openalex
- W2333741669 via openalex
- W2338836273 via openalex
- W2394940410 via openalex
- W2401169355 via openalex
- W2407038112 via openalex
- W2409201526 via openalex
- W2410916488 via openalex
- W2415535688 via openalex
- W2417044776 via openalex
- W2418499473 via openalex
- W2430356393 via openalex
- W2469087363 via openalex
- W4302596199 via openalex
- W80518653 via openalex
- W106243460 via openalex
- W141632864 via openalex
- W164119867 via openalex
- W201040832 via openalex
- W1423337030 via openalex
- W1742897810 via openalex
- W1782310487 via openalex
- W1965887584 via openalex
- W1967987476 via openalex
- W1981326009 via openalex
- W1981616577 via openalex
- W1984026768 via openalex
- W1984365059 via openalex
- W1986369528 via openalex
- W1986450389 via openalex
- W1988605646 via openalex
- W1996575935 via openalex
- W1998413277 via openalex
- W2000660883 via openalex
- W2000792140 via openalex
- W2000893929 via openalex
- W2009881284 via openalex
- W2010057733 via openalex
- W2012607678 via openalex
- W2014564190 via openalex
- W2015767866 via openalex
- W2019132745 via openalex
- W2021656047 via openalex
Cited by (9)
- Pharmacokinetic considerations for gonadotropin-releasing hormone agonists and antagonists to treat endometriosis 2025
- Efficacy and uterine bleeding patterns in initiating goserelin therapy during different menstrual phases in patients with adenomyosis: a prospective cohort study 2024
- A preliminary study on the effects of Xiang Shao granules on reproductive endocrinology in drugged ovariectomised rats 2024
- Hormone therapy for endometriosis and surgical menopause 2009
- Aromatase inhibitors prevent the estrogen rise associated with the flare effect of gonadotropins in patients treated with GnRH agonists 2008
- A Benefit-Risk Assessment of Medical Treatment for Uterine Leiomyomas 2002
- Endometriosis: An Overview of the Disease and Its Treatment 2000
- GnRH analogue in everyday gynecology, Is it possible to rationalize its use? 1999
- Etiology and Management of Chronic Pelvic Pain Syndromes 1997
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-05-13T22:11:08.331550+00:00
License: CC0
· commercial use OK